Sign in
4

Changes in Ownership

Kalaris Therapeutics, Inc. Filed Acc 0000899243-22-018526

Chief Commercial Officer sold 15,262 shares at $4.40 ($67,167)

From the SEC's structured data for this filing

Trades in this filing

VAN BEEK JEROEN B · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2022-05-17 Sale : show line 1 in the form −15,262 $4.40 $67,167 389,526 D
Open-market sales · 15,262 sh · avg $4.40 · $67,167
Loading xslF345X03/doc4.xml…